Lung-on-a-chip microdevice, right ventricular dysfunction as a predictor of survival, and lung ultrasound in community-acquired pneumonia

American Journal of Respiratory and Critical Care Medicine

Volumn 188, Issue 8, 2013, Pages 1028-

  Weis, Justin M ^a   Staicu, Serban A ^a   Chase, Karin S ^a   Trawick, David Roy ^a  

^a UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN 1; FLUORESCEIN ISOTHIOCYANATE; INTERLEUKIN 2; VANILLOID RECEPTOR 4; ANTIHYPERTENSIVE AGENT;

CANINE MODEL; CELL CULTURE; COMMUNITY ACQUIRED PNEUMONIA; CONCENTRATION (PARAMETERS); CULTURE MEDIUM; ECHOGRAPHY; EXPERIMENTAL DESIGN; EXTRACELLULAR MATRIX; HEART VENTRICLE FUNCTION; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; LABORATORY DEVICE; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; LUNG ON A CHIP MICRODEVICE; MICROVASCULAR ENDOTHELIAL CELL; NONHUMAN; NOTE; OXYGEN DIFFUSION; PRIORITY JOURNAL; STROMA CELL; TISSUE STRUCTURE; ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR MORTALITY; DETERIORATION; DISEASE ASSOCIATION; HEART AFTERLOAD; HEART RIGHT VENTRICLE EJECTION FRACTION; LUNG VASCULAR RESISTANCE; PROGNOSIS; PULMONARY HYPERTENSION; SURVIVAL; TREATMENT DURATION;

ANIMALS; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; HYPERTENSION, PULMONARY; INTERLEUKIN-2; LUNG; MALE; MICROFLUIDIC ANALYTICAL TECHNIQUES; MODELS, BIOLOGICAL; PNEUMONIA; PULMONARY EDEMA; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84886399043     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201303-0469RR     Document Type: Note

References (4)

1. Huh D, Leslie DC, Matthews BD, Fraser JP, Jurek S, Hamilton GA, Thorneloe KS, McAlexander MA, Ingebar DE. A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice. Sci Transl Med 2012;4:159ra147.
2. Baluna R, Vitetta ES. Vascular leak syndrome: a side effect of immunotherapy. Immunopharmacology 1997;37:117-132.
3. Thorneloe, KS, Cheung M, Bao W, Alsaid H, Lenhard S, Jian MY, Costell M, Maniscalco-Hauk K, Krawiec JA, Olzinski A, et al. An orally active TRPV4 channel blocker prevents and resolves pulmonary edema induced by heart failure. Sci Transl Med 2012;4:159ra148.
4. Assier E, Jullien V, Lefort J, Moreau JL, Di Santo JP, Vargaftig BB, Lapa e Silva JR, Theze J. NK cells and polymorphonuclear neutrophils are both critical for IL-2-induced pulmonary vascular leak syndrome. J Immunol 2004;172:7661-7668.